Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jul;1(4):201-10.
doi: 10.1002/emmm.200900032.

Jamming bacterial communication: new approaches for the treatment of infectious diseases

Jacqueline Njoroge  1 , Vanessa Sperandio
Affiliations
Review

Jamming bacterial communication: new approaches for the treatment of infectious diseases

Jacqueline Njoroge et al. EMBO Mol Med. 2009 Jul.

Erratum in

  • EMBO Mol Med. 2009 Sep;1(6-7):352-3

Abstract

The global rise of anti-microbial resistance, combined with the rapid rate of microbial evolution, and the slower development of novel antibiotics, underscores the urgent need for innovative therapeutics. We are facing a post-antibiotic era with a decreased armamentarium to combat infectious diseases. Development of novel drugs will rely on basic research aimed to increase our understanding of bacterial pathogenesis and the inter-cellular chemical signalling among bacterial cells. Such basic science, when combined with contemporary drug discovery technologies, may be translated into therapeutic applications to combat bacterial infections. In this review, we discuss many strategies aimed to interfere with bacterial cell-to-cell signalling via the quorum-sensing (QS) pathway to inhibit bacterial virulence and/or the development of microbial communities (known as biofilms), which are refractory to antibiotic treatment. QS antagonists should be viewed as blockers of pathogenicity rather than as anti-microbials and because QS is not involved in bacterial growth, inhibition of QS should not yield a strong selective pressure for development of resistance. QS inhibitors (QSIs) hold great expectations and we look forward to their application in fighting bacterial infections.

Keywords: Pseudomonas aeruginosa; Staphylococcus aureus; enterohemorrhagic E. coli (EHEC); inter-kingdom signalling; quorum sensing.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The relationship between QS and virulence in P. aeruginosa
The blue symbols indicate potential therapeutic targets. The green letters correspond to the targeted mechanisms in Table 1.
Figure 2
Figure 2. The relationship between QS and virulence in S. aureus
The blue symbols indicate potential therapeutic targets. The green letters correspond to the targeted mechanisms in Table 2.
Figure 3
Figure 3. The relationship between QS and virulence in EHEC
The red shows the effect of antibiotics on virulence and disease. The blue symbols indicate potential therapeutic targets. The green letters correspond to the targeted mechanisms in Table 3.
See this image and copyright information in PMC

References

    1. Balaban N, Goldkorn T, Gov Y, Hirshberg M, Koyfman N, Matthews HR, Nhan RT, Singh B, Uziel O. Regulation of Staphylococcus aureuspathogenesis via target of RNAIII-activating protein (TRAP) J Biol Chem. 2001;276:2658–2667. - PubMed
    1. Banin E, Vasil ML, Greenberg EP. Iron and Pseudomonas aeruginosabiofilm formation. Proc Natl Acad Sci USA. 2005;102:11076–11081. - PMC - PubMed
    1. Banin E, Brady KM, Greenberg EP. Chelator-induced dispersal and killing of Pseudomonas aeruginosacells in a biofilm. Appl Environ Microbiol. 2006;72:2064–2069. - PMC - PubMed
    1. Banin E, Lozinski A, Brady KM, Berenshtein E, Butterfield PW, Moshe M, Chevion M, Greenberg EP, Banin E. The potential of desferrioxamine-gallium as an anti-Pseudomonastherapeutic agent. Proc Natl Acad Sci USA. 2008;105:16761–16766. - PMC - PubMed
    1. Barraud N, Hassett DJ, Hwang SH, Rice SA, Kjelleberg S, Webb JS. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J Bacteriol. 2006;188:7344–7353. - PMC - PubMed

MeSH terms